{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:27Z","timestamp":1788393627533,"version":"build-2803163510"},"reference-count":28,"publisher":"Codon Publications","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.aller.2013.09.013","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T15:05:43Z","timestamp":1422025543000},"page":"62-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mortality and morbidity in patients with X-linked agammaglobulinaemia"],"prefix":"10.15586","volume":"43","author":[{"given":"H.","family":"Abolhassani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hirbod-Mobarakeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shahinpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mohammadinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mirminachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Shakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Samavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2013.09.013_bib0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000095469","article-title":"Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia","volume":"141","author":"Aghamohammadi","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.0105-2896.2005.00225.x","article-title":"Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling","volume":"203","author":"Lindvall","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.aller.2013.09.013_bib0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/eji.1830230306","article-title":"Diversity of immunoglobulin kappa light chain gene rearrangements and evidence for somatic mutation in V kappa IV family gene segments in X-linked agammaglobulinemia","volume":"23","author":"Timmers","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0020","first-page":"572","article-title":"Molecular characterization of Bruton's tyrosine kinase deficiency in 12 Iranian patients with presumed X-linked agammaglobulinemia","volume":"21","author":"Nasseri","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.aller.2013.09.013_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005792-199611000-00001","article-title":"X-linked agammaglobulinemia. A clinical and molecular analysis","volume":"75","author":"Ochs","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aller.2013.09.013_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","article-title":"X-linked agammaglobulinemia: report on a United States registry of 201 patients","volume":"85","author":"Winkelstein","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aller.2013.09.013_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.1080","article-title":"Multiple complications of IVIG therapy in a patient with Guillain\u2013Barre syndrome","volume":"67","author":"Steinberger","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.aller.2013.09.013_bib0045","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1186\/1757-1626-2-9078","article-title":"Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with chronic lymphocytic leukemia: a case report","volume":"2","author":"Milani","year":"2009","journal-title":"Cases J"},{"key":"10.1016\/j.aller.2013.09.013_bib0050","first-page":"347","article-title":"Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature","volume":"98","author":"Mathy","year":"1998","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.aller.2013.09.013_bib0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/eci.10.104","article-title":"Indications and safety of intravenous and subcutaneous immunoglobulin therapy","volume":"7","author":"Rezaei","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1067\/mpd.2002.127711","article-title":"Clinical findings leading to the diagnosis of X-linked agammaglobulinemia","volume":"141","author":"Conley","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.aller.2013.09.013_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","article-title":"Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study","volume":"104","author":"Plebani","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MPH.0b013e318180bb45","article-title":"Genotype\u2013phenotype correlation in Bruton's tyrosine kinase deficiency","volume":"30","author":"Teimourian","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.aller.2013.09.013_bib0075","first-page":"175","article-title":"Screening of the Bruton Tyrosine Kinase (BTK) gene mutations in 13 Iranian patients with presumed X-linked Agammaglobulinemia","volume":"3","author":"Aghamohammadi","year":"2004","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10875-008-9227-y","article-title":"Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina","volume":"29","author":"Basile","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2011.06239.x","article-title":"The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment","volume":"1238","author":"Rezaei","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.aller.2013.09.013_bib0140","first-page":"57","article-title":"Physicians awareness on primary immunodeficiency disorders in Iran","volume":"11","author":"Nourijelyani","year":"2012","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aller.2013.09.013_bib0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B-cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.aller.2013.09.013_bib0100","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.aller.2013.09.013_bib0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2249.1997.4831379.x","article-title":"Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies","volume":"109","author":"Buehring","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2013.09.013_bib0110","first-page":"335","article-title":"High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia","volume":"146","author":"Liese","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.aller.2013.09.013_bib0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijantimicag.2010.11.027","article-title":"Immunoglobulin treatment in primary antibody deficiency","volume":"37","author":"Maarschalk-Ellerbroek","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.aller.2013.09.013_bib0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2177\/jsci.25.337","article-title":"Intravenous immunoglobulin replacement therapy in X-linked agammaglobulinemia","volume":"25","author":"Kanegane","year":"2002","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.aller.2013.09.013_bib0125","first-page":"279","article-title":"Review of the studies on primary immunodeficiency disorder and vaccine-derived poliovirus","volume":"16","author":"Xia","year":"2010","journal-title":"Zhongguo Yi Miao He Mian Yi"},{"key":"10.1016\/j.aller.2013.09.013_bib0130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00431-008-0674-5","article-title":"Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis","volume":"167","author":"Mamishi","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.aller.2013.09.013_bib0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2005.11.002","article-title":"The health status and quality of life of adults with X-linked agammaglobulinemia","volume":"118","author":"Howard","year":"2006","journal-title":"Clin Immunol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054613002863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054613002863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:49:48Z","timestamp":1609454988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054613002863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0301054613002863"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2013.09.013","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality and morbidity in patients with X-linked agammaglobulinaemia","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2013.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 SEICAP. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}